Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug;29(4):487-93.
doi: 10.1007/s40620-016-0279-4. Epub 2016 Mar 14.

IgG4-related nephropathy

Affiliations
Free article
Review

IgG4-related nephropathy

Giacomo Quattrocchio et al. J Nephrol. 2016 Aug.
Free article

Abstract

IgG4-related disease (IgG4-RD) is a recently recognized disorder, often with multiple organ involvement, characterized by dense tissue infiltration of IgG4-positive plasma cells, storiform fibrosis, obliterative phlebitis and frequently elevated serum IgG4 concentration. The kidney can be involved either directly or indirectly. The most frequent direct renal manifestations of IgG4-RD are IgG4-related tubulointerstitial nephritis (TIN) and membranous glomerulonephropathy. Retroperitoneal fibrosis (RPF) is another condition that is frequently IgG4-related and that can indirectly affect the kidney causing ureteral obstruction and hydronephrosis. Contrast-enhanced computerized tomography, magnetic resonance imaging and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography show different imaging findings and are useful tools for monitoring therapeutic response. Steroid treatment is the first line of therapy, but relapsing or refractory forms of the disease are frequently observed and require more aggressive therapeutic approaches. At our centre, we treated three cases of aggressive IgG4-related TIN and two cases of IgG4-related RPF with an intensified, immune suppressive protocol, obtaining good results without severe adverse effects.

Keywords: Glucocorticoids; IgG4-related disease; IgG4-related kidney disease; Retroperitoneal fibrosis; Rituximab; Tubulointerstitial nephritis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ann Rheum Dis. 2015 Jan;74(1):14-8 - PubMed
    1. Annu Rev Pathol. 2014;9:315-47 - PubMed
    1. Kidney Int. 2014 Feb;85(2):251-7 - PubMed
    1. Autoimmun Rev. 2014 Dec;13(12):1203-10 - PubMed
    1. Rheumatol Int. 2015 Jun;35(6):1093-101 - PubMed

MeSH terms

Substances